CEDEARs de Farma & Biotecnología
Listado de CEDEARs etiquetados como Farma & Biotecnología, con precios, ratios y datos actualizados en Argentina.
| Fijar | Ticker | Empresa | Mercado | Precio | Var. % | Ratio | Ticker original |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | NYSE | $ 46.300 | +1,14% | 10 | ABBV | ||
| Amgen Inc. | NASDAQ | $ 23.310 | -0,34% | 30 | AMGN | ||
| Astrazeneca Plc | NYSE | $ 66.950 | -0,78% | 4 | AZN | ||
| Bayer AG | FRANKFURT | $ 29.500 | +1,72% | 3 | BAYN | ||
| Biogen Inc. | NASDAQ | $ 28.920 | -1,03% | 13 | BIIB | ||
| Bristol-Myers Squibb Company | NYSE | $ 32.160 | -1,65% | 3 | BMY | ||
| Gilead Sciences, Inc. | NASDAQ | $ 63.275 | -0,59% | 4 | GILD | ||
| GSK Plc. | NYSE | $ 20.030 | +1,11% | 4 | GSK | ||
| iShares Nasdaq Biotechnology ETF | NASDAQ | $ 12.100 | -2,81% | 27 | IBB | ||
| Johnson & Johnson | NYSE | $ 27.640 | +0,95% | 15 | JNJ | ||
| Eli Lilly and Company | NYSE | $ 36.320 | +0,39% | 56 | LLY | ||
| Merck & Co. Inc. | NYSE | $ 47.200 | -0,13% | 5 | MRK | ||
| Moderna Inc | NASDAQ | $ 18.330 | -9,21% | 19 | MRNA | ||
| Novo Nordisk A/S | NYSE | $ 8.955 | -1,1% | 7 | NVO | ||
| Novartis Ag | NYSE | $ 60.825 | +0,25% | 4 | NVS | ||
| Pfizer Inc. | NYSE | $ 11.940 | +0,25% | 4 | PFE | ||
| VERTEX PHARMACEUTICALS INC | NYSE | $ 7.975 | -2,03% | 101 | VRTX |